semaglutide and asthma ADA 2026 Weight-loss drugs can ease migraines
Description
Cagrilintide has a long half-life, supporting once-weekly subcutaneous dosing
People with the risk allele often have higher baseline appetite and lower resting energy expenditure, meaning they burn fewer calories at rest
The concept of using microneedles (MNs) for transdermal drug delivery was first patented by Gerstel and Place in 1976
The final section of this review synthesizes these insights into a forward-looking perspective on the future of peptide therapeutics and articulates why the rediscovery of dormant biology, when guided by modern pharmacologic principles, may represent the most productive frontier in drug discovery
The mean weight loss in the semaglutide group was 13.6%, compared with 2.2% in the placebo group
Cost and coverage remain the biggest access barriers
